Skip to content
Credit reportVerdict and grounds
Made on 21-11-2026 at 14:56
Reference CK-0774645958-20261121

Mobimed

ActivePrivate limited company0774.645.958Krommebeekpark 11, 8800 Roeselare
Wholesale of pharmaceutical and medical goods (NACE 46460) · founded in 2021 · 1 employee on 31-12-2025

Sources: the KBO register on 21-11-2026; the National Bank, 2025 annual accounts filed on 15-04-2026; the Belgian Official Gazette, latest deed of 06-03-2023.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 26,953 micro companies in the wholesale trade sector (NACE 46) is 0.4%.
Gross margin
€384,166
▲ 8.1 times that of 2024
Net result
€197,803
▲ over 63 times that of 2024
Equity
€370,569
▼ 0.6% against 2024
Cash
€168,735
▲ 7.9 times that of 2024

Grounds

the facts the verdict rests on, each with its source
  1. Mobimed made a profit in every financial year since 2022. The profit of 2025, €197,803, is the highest so far.Annual accounts 2022 to 2025 page 2
  2. Equity stands at €370,569, or 61.7% of the balance sheet total of €600,671. The solvency of 61.7% is higher than at 68% of the 10,808 companies filing abbreviated accounts in wholesale trade (NACE 46) in 2025.Annual accounts 2025 page 2
  3. Mobimed paid out €200,000 in dividends to , 101% of the profit of 2025. Because of the dividend and €207,610 higher other debts due within one year, solvency fell from 88.5% to 61.7%.Annual accounts 2025 page 2
  4. The last four annual accounts came in on time. The 2025 accounts were filed 107 days before the end of the term.National Bank, filing of 15-04-2026 page 5
  5. holds all the shares. Its equity stood at €3.0m on 31-12-2025. That parent has 2 holdings.Annual accounts 2025 of page 4

Representation

Each director alone represents Mobimed. The directors are . and ISIDOR.

Articles of association, Belgian Official Gazette of 30-09-2021, deed 21356959

Mobimed · 0774.645.958 · credit report of 21-11-2026Page 1 of 6
Mobimed0774.645.958 · report of 21-11-2026

Financial situation

Annual accounts 2022 to 2025, as filed with the National Bank

Gross margin and net resultin euro

2022239,793202369,163202447,3742025384,1662022142,06120237,69920243,1212025197,803
gross marginnet result

Equity and debtsin euro

2022202320242025370,569230,102
equitydebts

Cashin euro

2022105,268202311,511202421,4072025168,735
on the balance sheet date
Financial year202215 months202320242025Trend
Results
Gross margin€239,793€69,163€47,374€384,166
Operating result€189,157€10,901€4,293€262,880
Net result€142,061€7,699€3,121€197,803
Balance sheet at the closing date
Equity€361,946€369,645€372,766€370,569
Debts€224,719€84,366€48,365€230,102
Debts due within one year€224,719€72,866€48,365€230,102
Cash€105,268€11,511€21,407€168,735
Balance sheet total€586,665€454,012€421,131€600,671
Operations
Employees in full-time equivalents1.71.00.41.0
Ratios
Solvency61.7%81.4%88.5%61.7%
Liquidity2.415.507.482.43

Source: Annual accounts 2025, abbreviated format, filed on 15-04-2026 (2026-00080117); Annual accounts 2024, abbreviated format, filed on 02-06-2025 (2025-00112979); Annual accounts 2022 to 2023, filed from 04-07-2023 to 10-07-2024 (2023-00222237, 2024-00230859).

The operating result of 2025 is 61 times that of 2024.

Debts rose by €181,737 in 2025. A dividend stands among the debts on the balance sheet date until it is paid.

The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.

The financial year to 31-12-2022 ran for 15 months.

Mobimed · 0774.645.958 · credit report of 21-11-2026Page 2 of 6
Mobimed0774.645.958 · report of 21-11-2026

Board, signature and ownership

Position on 21-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

Each director alone represents Mobimed. The directors are . and ISIDOR.

Articles of association, Belgian Official Gazette of 30-09-2021, deed 21356959

Board

two directors in office
Director (not named in the articles)since 27-09-2021
term without a fixed enddeed of 30-09-2021
Director (not named in the articles)since 27-09-2021
term without a fixed enddeed of 30-09-2021

. also sits on the boards of 2 other companies. ISIDOR also sits on the boards of 2 other companies.

Ownership and group

Shareholders

holds all the shares. Its equity stood at €3.0m on 31-12-2025.

Annual accounts 2025 of

Mobimed · 0774.645.958 · credit report of 21-11-2026Page 3 of 6
Mobimed0774.645.958 · report of 21-11-2026

Group

has 2 holdings (2025 accounts).

Country Company Equity Result
Belgium 2
BE Mobimedthis company €370,569 result €197,803
BE 50% -€22,732 result -€15,966

Source: List of holdings in the 2025 accounts of . Every holding stands with its own latest accounts.

Mobimed · 0774.645.958 · credit report of 21-11-2026Page 4 of 6
Mobimed0774.645.958 · report of 21-11-2026

Events and comparison

The last 24 months, newest first

Annual accounts 2025 filed, 107 days before the deadline.

NBB filing

Highest result from 2022 to 2025. The operating result of €262,880 and the net result of €197,803 are both a record.

Financial

Annual accounts 2024 filed, 59 days before the deadline.

NBB filing

Weakest financial year. The net result drops to €3,121, the lowest from 2022 to 2025. It recovers the following year.

Financial

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as Mobimed has now: micro, 5 to 10 years old, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 94.9% were still trading, 3.5% had stopped another way and 1.6% had gone bankrupt.

still trading 94.9% stopped another way 3.5% bankrupt 1.6%

The return on assets of Mobimed, 32.9%, is higher than at 95% of the 10,736 companies filing abbreviated accounts in wholesale trade (NACE 46) in 2025.

Other findings

Peppol

Reachable for e-invoices since 28-12-2025, under 0208:0774645958.

Sanctions lists

Staff

1 employee on 31-12-2025, 1.0 full-time equivalents on average over the year.

Mobimed · 0774.645.958 · credit report of 21-11-2026Page 5 of 6
Mobimed0774.645.958 · report of 21-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units21-11-2026KBO 0774.645.958
National Bank of BelgiumAnnual accounts 2025, abbreviated format15-04-20262026-00080117
National Bank of BelgiumAnnual accounts 2024, abbreviated format02-06-20252025-00112979
National Bank of BelgiumAnnual accounts 2022 to 202304-07-2023 to 10-07-20242023-00222237, 2024-00230859
Belgian Official GazetteArticles of association with the signing rule30-09-2021deed 21356959
Peppol DirectoryRegistration for e-invoices28-12-20250208:0774645958
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name19-11-2026
CheckedChecked score, bankruptcy probability, credit, comparable companies20-11-2026bankruptcy model of 2 October 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 20-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

Mobimed · 0774.645.958 · credit report of 21-11-2026Page 6 of 6